Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 601

1.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr; Mirtazapine vs. Paroxetine Study Group..

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50.

PMID:
12213688
2.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
3.
4.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group..

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
5.

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.

Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.

Int Clin Psychopharmacol. 2003 May;18(3):133-41.

PMID:
12702891
6.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
7.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group..

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
8.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team..

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
9.
11.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

12.

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.

J Clin Psychiatry. 2003 Apr;64(4):413-20.

PMID:
12716243
13.

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.

Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H; Mirtazapine in the Nursing Home Study Group..

Curr Med Res Opin. 2003;19(8):737-46.

PMID:
14687445
14.

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.

J Clin Psychopharmacol. 2006 Feb;26(1):75-8.

PMID:
16415711
15.
16.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
17.

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.

J Clin Psychiatry. 2001 Jun;62(6):413-20.

PMID:
11465517
18.

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.

Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015.

PMID:
19345072
19.

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.

Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y.

Int Clin Psychopharmacol. 2000 Jan;15(1):43-8.

PMID:
10836286
20.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
Items per page

Supplemental Content

Support Center